Apparently not. In a FASTER-related study, researchers from seven centers who studied more than 10,000 patients concluded that the association between subclinical hypothyroidism and lower pediatric IQ does not appear to result from obstetric factors. The finding is of special note given controversy on this question raised by recent studies.
Apparently not. In a FASTER-related study, researchers from seven centers who studied more than 10,000 patients concluded that the association between subclinical hypothyroidism and lower pediatric IQ does not appear to result from obstetric factors. The finding is of special note given controversy on this question raised by recent studies.
Studying patients enrolled in the FASTER Trial, investigators evaluated whether there's an association between subclinical hypothyroidism or antithyroid antibodies and adverse obstetric outcomes.
Blood tests were performed on the 10,990 patients for thyroid stimulating hormone (TSH), free thyroxine (FT4), antithyroglobulin antibody (antiTG), and antithyroid peroxidase antibody (antiTPO). Defining subclinical hypothyroidism as high TSH with normal-low FT4 or normal TSH with low FT4 and comparing patients to healthy controls, the researchers evaluated pregnancy and pediatric outcomes and confounding factors. They also compared patients with antiTG and/or antiTPO to those without these antibodies.
Cleary-Goldman J, Malone FD, Messerlian G, et al. Subclinical hypothyroidism and pregnancy outcomes. Am J Obstet Gynecol. 2005;193(6 suppl):S20. (Abstract 6).
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More